Diseases, Conditions, Syndromes

New light shed on cause of lung injury in severe flu

While some scientists report engineering a super virulent strain of the H5N1 influenza virus, which could potentially wipe out a significant percentage of the human population, another group of researchers from the United ...

Diseases, Conditions, Syndromes

Short, sharp shock treatment for E. coli

A short burst of low voltage alternating current can effectively eradicate E. coli bacteria growing on the surface of even heavily contaminated beef, according to a study published in the International Journal of Food Safety, ...

Medical research

Stem cells repair lung damage after flu infection

Guided by insights into how mice recover after H1N1 flu, researchers at Harvard Medical School and Brigham and Women's Hospital, together with researchers at A*STAR of Singapore, have cloned three distinct stem cells from ...

Medical research

Can antivirulence drugs stop infections without causing resistance?

Antivirulence drugs disarm pathogens rather than kill them, and although they could be effective in theory, antivirulence drugs have never been tested in humans. A new study to be published in the online journal mBio on Tuesday, ...

Diseases, Conditions, Syndromes

Experimental vaccine protects monkeys from blinding trachoma

An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a National ...

Diseases, Conditions, Syndromes

Large study reaffirms H1N1, seasonal flu vaccine safety

Back in spring 2009, the H1N1 influenza virus crossed the U.S. border and raised concerns that it might cause a full-scale epidemic in the fall. The Food and Drug Administration worked with other Health and Human Services ...

Diseases, Conditions, Syndromes

Potential treatment for deadly E. coli disease

A potential life-saving treatment for severe E. coli food poisoning outbreaks - developed more than a decade ago - hasn't gone forward into clinical trials because of lack of commercial interest.

page 5 from 6